Literature DB >> 7608281

Biochemical markers of bone turnover in lactating and nonlactating postpartum women.

M Sowers1, D Eyre, B W Hollis, J F Randolph, B Shapiro, M L Jannausch, M Crutchfield.   

Abstract

We measured two bone-formation markers, osteocalcin and bone-specific alkaline phosphatase, and one bone-resorption marker, N-telopeptide, in a longitudinal study in order to describe levels of these markers in lactating and nonlactating women after parturition. This 18-month postpartum period included an initial 6 months in which a 5% short-term bone loss occurred at both spine and femoral neck among breast-feeding women. The second part of the 18-month period was characterized by bone recovery among women who had lost bone. These bone-change characteristics provided an opportunity to evaluate the performance of biochemical markers during both bone loss and recovery and to identify environmental exposures during lactation associated with bone turnover. The eligible population comprised 115 women whose bone-turnover markers were measured at 2 weeks (baseline) and at 2, 4, 6, 12, and 18 months after parturition. Participants reported reproductive characteristics, diet, physical activity, use of medications, and infant-feeding practices at each contact. Women were grouped according to lactation duration: 0-1 months, 2-5 months, and 6 months or more. Women who breast-fed for at least 6 months had significantly different levels of all three bone-turnover markers compared with the levels in bottle-feeding controls, which were indicative of substantially increased bone turnover. Factors that predicted the difference in biochemical markers from baseline to 6-month values by regression analysis were lactation of 2-6 months duration and lactation for 6 months or more. Dietary calcium intake, physical activity level, and body size did not explain the differences in the change from the baseline level to the 6-month level, a period of time that corresponded with bone loss in the lactating women. Factors that predicted the differences in bone-turnover markers between 6 and 18 months (the time of bone-mass recovery) were lactation status and number of months to resumption of menses. By the 18-month observation, there was no difference in the mean values for the measured bone-turnover markers among the three lactation groups. This suggests that menstrual activity, rather than diet or physical activity, is the primary factor in bone-mass recovery after the bone loss of lactation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7608281     DOI: 10.1210/jcem.80.7.7608281

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Bone turnover markers during lactation, postpartum amenorrhea and resumption of menses.

Authors:  D Holmberg-Marttila; A Leino; H Sievänen
Journal:  Osteoporos Int       Date:  2003-02-12       Impact factor: 4.507

2.  IOM committee members respond to Endocrine Society vitamin D guideline.

Authors:  Clifford J Rosen; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; JoAnn E Manson; Susan T Mayne; A Catharine Ross; Sue A Shapses; Christine L Taylor
Journal:  J Clin Endocrinol Metab       Date:  2012-03-22       Impact factor: 5.958

3.  Increased PTHrP and decreased estrogens alter bone turnover but do not reproduce the full effects of lactation on the skeleton.

Authors:  Laleh Ardeshirpour; Susan Brian; Pamela Dann; Joshua VanHouten; John Wysolmerski
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

4.  A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover.

Authors:  Mara J Horwitz; Mary Beth Tedesco; Susan M Sereika; Linda Prebehala; Caren M Gundberg; Bruce W Hollis; Alessandro Bisello; Adolfo Garcia-Ocaña; Raquel M Carneiro; Andrew F Stewart
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

5.  Type I collagen as a marker of bone metabolism in sickle cell hemoglobinopathies.

Authors:  D M Bolarin; P Swerdlow; A M Wallace; L Littsey
Journal:  J Natl Med Assoc       Date:  1998-01       Impact factor: 1.798

6.  The influence of lactation on BMD measurements and TBS: a 12-month follow-up study.

Authors:  F M F Grizzo; M de Andrade Pereira; L B M Marchiotti; F Guilhem; T da Silva Santos; C M Dell' Agnolo; W A de Melo; M de Medeiros Pinheiro; M D de Barros Carvalho; S M Pelloso
Journal:  Osteoporos Int       Date:  2021-01-21       Impact factor: 4.507

7.  Beyond bone biology: Lessons from team science.

Authors:  Mone Zaidi; Daria Lizneva; Sakshi Gera; Charit Taneja; Funda Korkmaz; Anisa Gumerova; Kseniia Ievleva; Naseer Ahmad; Vitaly Ryu; Li Sun; Se-Min Kim; Maria I New; Shozeb Haider; Jameel Iqbal; Clifford Rosen; Tony Yuen
Journal:  J Orthop Res       Date:  2020-07-22       Impact factor: 3.494

8.  Evaluation of markers of bone turnover during lactation in African-Americans: a comparison with Caucasian lactation.

Authors:  Raquel M Carneiro; Linda Prebehalla; Mary Beth Tedesco; Susan M Sereika; Caren M Gundberg; Andrew F Stewart; Mara J Horwitz
Journal:  J Clin Endocrinol Metab       Date:  2012-12-28       Impact factor: 5.958

9.  A meta-analysis of breastfeeding and osteoporotic fracture risk in the females.

Authors:  X Duan; J Wang; X Jiang
Journal:  Osteoporos Int       Date:  2016-08-30       Impact factor: 4.507

Review 10.  Actions of pituitary hormones beyond traditional targets.

Authors:  Mone Zaidi; Maria I New; Harry C Blair; Alberta Zallone; Ramkumarie Baliram; Terry F Davies; Christopher Cardozo; James Iqbal; Li Sun; Clifford J Rosen; Tony Yuen
Journal:  J Endocrinol       Date:  2018-03-19       Impact factor: 4.286

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.